IMMUNOPHARMACOLOGY Flashcards

(60 cards)

1
Q

List 7 different types of immunosuppressive drugs?

A
Glucocorticoids
Calcineurin Inhibitors
Proliferation Signal Inhibitors
Inhibitors of Angiogenesis
Cytotoxic Agents
Other Agents
Immunosuppressive Antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glucocorticoids effects and how does it modulate its effects?

A

• Glucocorticoids have broad anti-inflammatory
effects.
• Glucocorticoids act by binding to the cytosolic
glucocorticoid receptor.
• The glucocorticoid-glucocorticoid receptor
complex translocates to the nucleus and binds to
glucocorticoid response elements (GREs) in the
promoter region of specific genes, either upregulating or down-regulating gene expression
• Glucocorticoids down-regulate the expression
of many inflammatory mediators.
• The overall effect of glucocorticoid administration
is profoundly anti-inflammatory and
immunosuppressive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GLUCOCORTICOIDS:

ANTI-INFLAMMATORY MOA

A

• Glucocorticoids relieve pain due to the modulation
of inflammatory responses.
• Glucocorticoids suppress several inflammatory
pathways.
• Glucocorticoids inhibit prostaglandin synthesis
through independent mechanisms:
• Inhibition of PLA2
• Reduction of transcription of COX-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GLUCOCORTICOIDS: ADVERSE EFFECTS?

A

• Short-term use: hypertension, hyperglycemia,
immunosuppression, psychotic reactions, and
cognitive impairment.
• Long-term use: myopathy, Cushing’s syndrome,
and osteoporosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GLUCOCORTICOIDS: USES?

A

• Used to prevent and treat transplant rejection.
• Used to treat autoimmune disorders such as
rheumatoid arthritis, SLE, psoriasis, asthma, and
IBD.
• In palliative care glucocorticoids are used to
alleviate pain, nausea, and fatigue.
• Used to treat pain, including neuropathic and bone pain. Dexamethasone is usually preferred because of its long half-life and low mineralocorticoid
effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 2 Calcineurin inhibitors?

A
  • Cyclosporine

* Tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cyclosporine moa?

A
• Calcineurin is a phosphatase necessary for activation of a Tcell-specific transcription factor: NFAT.
• NFAT is required for the
induction of cytokine genes.
• Cyclosporine forms a
complex with cyclophilin, an
immunophilin.
• This complex inhibits
calcineurin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclosporine AE?

A

• Main adverse reactions: Nephrotoxicity, tremor,
hypertension, hyperglycemia, hyperlipidemia,
osteoporosis, hirsutism, gum hyperplasia.
• Nephrotoxicity is limiting and occurs in the
majority of patients treated. Major indication
for cessation of therapy.
• Very little bone marrow toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cyclosporine drug interactions and uses?

A

• Primarily metabolized by CYP3A4: involved in
many drug interactions.

uses:
• Organ transplantation
• Uveitis
• Rheumatoid arthritis
• Psoriasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tacrolimus moa?

A
  • Tacrolimus binds to FK-binding protein (FKBP).
  • FKBP is an immunophilin.
  • The tacrolimus-FKBP complex inhibits calcineurin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Tacrolimus AE?

A
  • Nephrotoxicity
  • Neurotoxicity
  • Hyperglycemia
  • Hypertension
  • Hyperkalemia
  • GI complaints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TACROLIMUS: USES?

A

• Prevention of rejection of transplanted kidneys,
liver or heart.
• Topical formulation is used for atopic dermatitis
and psoriasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SIROLIMUS category and moa?

A

PROLIFERATION SIGNAL INHIBITORS

• Structurally similar to tacrolimus.
• Sirolimus binds to FKBP.
• But the sirolimus-FKBP complex does not inhibit
calcineurin.
• Instead, it inhibits the serine-threonine kinase
mTOR.
• Blockade of mTOR blocks IL-2-driven T-cell
proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sirolimus AE?

A
• Myelosuppression
• Hepatotoxicity
• Diarrhea
• Hypertriglyceridemia
• Pneumonitis
• Headache.
• Nephrotoxicity is less common than with
calcineurin inhibitors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sirolimus uses?

A

• Renal transplantation.
• Sirolimus-eluting coronary stents are used to
inhibit restenosis of the blood vessels in patients
with severe CAD by reducing cell proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thalidomide category, actions, and uses?

A

INHIBITORS OF ANGIOGENESIS

  • Its mechanism of action is unclear.
  • Inhibits synthesis of TNF-α.
  • Inhibits angiogenesis.
  • Thalidomide is now called an immunomodulatory drug.
  • Indicated for the treatment of patients with erythema nodosum leprosum and multiple myeloma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Two categories falling under cytotoxic agents?

A
  • ANTIMETABOLITES

* ALKYLATING AGENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name 4 antimetabolites?

A
  • Azathioprine
  • Methotrexate
  • Mycophenolate mofetil
  • Leflunomide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AZATHIOPRINE: ADVERSE EFFECTS?

A
  • Bone marrow suppression
  • GI disturbances
  • Increase in infections and malignancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Azathioprine moa?

A

• Purine antimetabolite.
• Prodrug of 6-mercaptopurine.
• Converted to 6-MP.
• 6-MP is converted to metabolites that inhibit de
novo purine nucleotide synthesis.
• This leads to suppression of B and T cell
function, of immunoglobulin production and of
IL-2 secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AZATHIOPRINE: DRUG INTERACTIONS?

A

• Much of the drug’s inactivation depends on
xanthine oxidase.
• Patients who are also receiving allopurinol for
control of hyperuricemia should have the dose of
azathioprine reduced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

AZATHIOPRINE: USES?

A
  • Prevention of organ transplant rejection

* Severe rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Methotrexate moa?

A

• Methotrexate’s main mechanism of action at the
low doses used in rheumatic diseases is inhibition of aminoimidazolecarboxamide
ribonucleotide (AICAR) transformylase
• AICAR transformylase catalyzes the penultimate
and final steps in de novo purine biosynthesis
which lead to synthesis of IMP.
• Inhibition of AICAR transformylase leads to
accumulation of AMP.
• AMP is released and converted extracellularly to
adenosine
• Adenosine is a potent inhibitor of inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

METHOTREXATE: ADVERSE EFFECTS?

A
  • Nausea
  • Mucosal ulcers
  • Leukopenia
  • Anemia
  • GI ulcerations
  • Hepatotoxicity
  • Cirrhosis is rare.
  • Hypersensitivity pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Methotrexate contraindicated and how to reduce toxicity?
• Methotrexate toxicity can be reduced with leucovorin or folic acid. • Methotrexate is contraindicated in pregnancy.
26
METHOTREXATE: USES?
* Rheumatoid arthritis * Psoriasis * Psoriatic arthritis * Ankylosing spondylitis * Systemic lupus erythematosus
27
MYCOPHENOLATE MOFETIL moa?
• Mycophenolate mofetil is converted into mycophenolic acid. • Mycophenolic acid inhibits inosine monophosphate dehydrogenase, an enzyme in the de novo pathway of guanosine triphosphate (GTP) synthesis.
28
Mycophenolate mofetil action?
• This action suppresses both B- and Tlymphocyte activation. • Lymphocytes are particularly susceptible to inhibitors of the de novo pathway because they lack the enzymes necessary for the salvage pathway.
29
MYCOPHENOLATE MOFETIL: | ADVERSE EFFECTS
* Nausea, vomiting, diarrhea, abdominal pain. * Headache * Hypertension * Reversible myelosuppression
30
MYCOPHENOLATE MOFETIL: USES?
* Prophylaxis of transplant rejection. | * SLE.
31
LEFLUNOMIDE moa?
``` • Prodrug of teriflunomide. • Teriflunomide inhibits dihydroorotate dehydrogenase. • This decreases levels of UMP. • UMP is essential for the synthesis of pyrimidines. ```
32
LEFLUNOMIDE: ADVERSE EFFECTS?
* Diarrhea. * Reversible alopecia * Rash * Myelosuppression * Increases in aminotransferase activity. * CBC and liver function tests should be monitored. * Carcinogenic and teratogenic in animals. * Contraindicated in pregnancy.
33
LEFLUNOMIDE: USES?
* Rheumatoid arthritis * SLE * Myasthenia gravis
34
Cyclophosphamide category and action?
ALKYLATING AGENTS • Cyclophosphamide is one of the most effective immunosuppressive drugs available. • Cyclophosphamide destroys proliferating lymphoid cells. • It also alkylates DNA and other molecules in resting cells.
35
CYCLOPHOSPHAMIDE: ADVERSE EFFECTS?
``` • Infertility • Bone marrow suppression • Hemorrhagic cystitis • Rarely, bladder carcinoma. • Acrolein, a metabolite, is responsible for the urinary toxicities. • Long-term use increases the risk of infection and malignancy. ```
36
CYCLOPHOSPHAMIDE: USES?
• Used to treat SLE and other autoimmune diseases.
37
HYDROXYCHLOROQUINE moa and ae?
• Mechanism of anti-inflammatory action is unclear. AE: • Serious adverse effects are rare. • Hemolysis in patients with G6PD deficiency. • Retinal damage: vision should be monitored.
38
HYDROXYCHLOROQUINE: USES?
• Moderately effective for mild rheumatoid arthritis. • Usually well tolerated. • Often used with other drugs, particularly methotrexate and sulfasalazine. • Also used for lupus erythematosus. • May require 3-6 months to show clinical benefit
39
SULFASALAZINE constituents and metabolic activation?
• Sulfasalazine consists of sulfapyridine and 5- aminosalicylic (5-ASA) connected by a diazo bond. • Metabolized by bacteria in the colon to the constituent moieties. • The sulfapyridine is probably the active moiety in the treatment of rheumatoid arthritis. • The 5-ASA moiety is thought to be important in ulcerative colitis.
40
SULFASALAZINE: ADVERSE EFFECTS?
* Nausea, vomiting. * Headache, rash. * Neutropenia. * Thrombocytopenia is very rare. * Drug-induced lupus is rare. * Hemolysis in patients with G6PD deficiency.
41
SULFASALAZINE: USES?
* Ulcerative colitis * Rheumatoid arthritis * Crohn's disease * Ankylosing spondylitis
42
Name 2 polyclonal antibodies?
* Antilymphocyte & Antithymocyte Antibodies | * Rho(D) Immune Globulin
43
• Two types of antisera directed against lymphocytes are available: uses?
* Antilymphocyte globulin (ALG) * Antithymocyte globulin (ATG) * Used for stem cell transplantation. * Also used for solid organ transplantation.
44
RHO(D) IMMUNE GLOBULIN preparation and use?
• Rho (D) immune globulin is a preparation of human IgG containing antibodies against the Rho (D) antigen of the red cell. • Used for prevention of Rh hemolytic disease of the newborn.
45
MONOCLONAL ANTIBODIES
* TNF-alpha INHIBITORS | * OTHER MONOCLONAL ANTIBODIES
46
Lst three tnf-alpha inhibitors? MOA?
* Adalimumab * Infliximab * Etanercept • TNF-α inhibitors bind to TNF-α and prevent its interaction with its receptors.
47
TNF-alpha INHIBITORS: ACTIONS?
• Blocking TNF-α action results in suppression of inflammatory cytokines and adhesion molecules involved in leukocyte activation and migration.
48
Overview adalimumab and uses?
``` • Fully human IgG1 anti-TNF monoclonal antibody. USES • Rheumatoid arthritis • Psoriatic arthritis • Ankylosing spondylitis • Crohn's disease • Ulcerative colitis ```
49
Overview of inflimab and uses?
``` • Chimeric monoclonal antibody. USES • Rheumatoid arthritis • Psoriatic arthritis • Ankylosing spondylitis • Crohn's disease • Ulcerative colitis ```
50
Overview and uses of Etanercept?
``` • Not a true Mab. • Contains the ligand-binding portion of human TNF-α receptor fused to Fc portion of human IgG1. USES • Rheumatoid arthritis • Ankylosing spondylitis • Psoriatic arthritis ```
51
ANTI-TNF-alpha DRUGS: ADVERSE EFFECTS
• Cytopenias can occur. CBC should be monitored. • TNF inhibitors increase risk of infections. • TNF inhibitors should not be given to patients with an active infection. • Live vaccinations should not be given to patients on TNF inhibitor therapy. • Patients should be screened for TB and HBV infection. • TNF inhibitors may increase risk of malignancies. • TNF inhibitors may increase risk of GI ulcers and large bowel perforation. • TNF inhibitors can induce formation of anti-drug antibodies. These antibodies may interfere with drug efficacy and correlate with infusion site reactions. • TNF inhibitors can exacerbate HF.
52
Omalizumab moa and use?
• Anti-IgE recombinant humanized monoclonal antibody. • Binds to IgE and prevents IgE from binding to mast cells and basophils, thereby preventing release of inflammatory mediators after allergen exposure. • Used in asthma refractory to inhaled corticoids and evidence of allergic sensitization. • Also approved for chronic urticaria.
53
Basiliximab moa and use?
* IL-2 receptor antagonist. * Chimeric human-mouse IgG. * Binds to the IL-2 receptor. * Used to prevent renal transplant rejection.
54
Rituximab moa and uses?
• Chimeric murine-human monoclonal antibody that binds to the CD20 molecule on B lymphocytes. • Causes depletion of circulating B cells. • Used for treatment of non-Hodgkin’s lymphoma and chronic lymphocytic leukemia. • Also approved for the treatment of rheumatoid arthritis.
55
Anakinra action and uses?
• IL-1 receptor antagonist. • Recombinant version of the naturally occurring human IL-1RA that prevents IL-1 from binding to its receptor. • Approved for moderate to severe rheumatoid arthritis.
56
ABATACEPT overview and use?
* Fusion protein that interferes with T-cell activation. | * Used for moderate to severe rheumatoid arthritis.
57
List 3 immunostimulants?
* Aldesleukin * Interferons * Bacillus Calmette-Guérin (BCG)
58
ALDESLEUKIN structure and use?
• Recombinant interleukin-2 (IL-2). • Indicated for treatment of renal cell carcinoma and malignant melanoma.
59
Interferons alpha, beta, and gamma uses?
• Interferon-alpha is used in hairy cell leukemia, chronic myelogenous leukemia, malignant melanoma, Kaposi's sarcoma, and hepatitis B and C infections. • Interferon-beta is approved for use in relapsing multiple sclerosis. • Interferon-gamma is approved for treatment of chronic granulomatous disease. 106 BACILLUS CALMETTE-GUÉRIN
60
BACILLUS CALMETTE-GUÉRIN (BCG) uses and ae?
• Attenuated, live culture of Mycobacterium bovis. • By unclear mechanisms, it is active against tumors. • It is indicated for the treatment and prophylaxis of carcinoma of the urinary bladder. • Adverse effects include hypersensitivity, shock, chills, fever, malaise, and immune complex disease.